With respect to the wider GLP-1 drug class, the UK SmPCs for semaglutide (available on the electronic Medicines Compendium, emc) and tirzepatide (Mounjaro SmPC, emc) document GI adverse effects including nausea, vomiting, diarrhoea, constipation, and dyspepsia as well-characterised class effects
There are many signs that can tell you if you have low levels of this essential nutrient in your body
Allergic Reactions: Patients who have had allergic reactions to semaglutide or any of its components should not use this medication
Dans ce guide complet, nous analyserons les preuves scientifiques les plus rcentes afin de rpondre aux principales questions que se posent les patients et les professionnels de sant
GLP-1 strongly suppresses appetite, slows gastric emptying, and stimulates insulin while suppressing glucagon